Learn more and donate: http://www.maps.org/
Amanda Feilding: From Taboo to Treatment – The Evolution of Psychedelic Medicine
2017 Psychedelic Science Conference
A six-day global gathering of the international scientific community in ...
James Fadiman & Sophia Korb: Microdosing – The Phenomenon, Research Results & Startling Surprises
Learn more and donate: http://www.maps.org/
James Fadiman, PhD, and Sophia Korb, PhD
Microdosing: The Phenomenon, Research Results, and Startling Surprises
2017 Psychedelic Science Conference
A six-day global gathering of the international scientific ...
Franz Vollenweider: 5HT2A Receptor Agonists & Mood Disorders – Mood, Empathy & Social Pain
Learn more and donate: http://www.maps.org/
Franz Vollenweider, MD
Psychedelic 5HT2A Receptor Agonists
Enhance Mood and Empathy and Reduce Social Pain in Healthy Humans: Implication for Mood Disorders
2017 Psychedelic Science Conference
A six-day ...
Bruno Gomes: Plant or Psychedelic Medicine? Understanding the Ayahuasca & Ibogaine Healing Process
Learn more and donate: http://www.maps.org/
Bruno Gomes, MA
Plant Medicine or Psychedelic Medicine? Understanding the Healing Processes with Ayahuasca and Ibogaine
2017 Psychedelic Science Conference
A six-day global gathering of the international ...
Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico – Thomas Kingsley Brown
http://psychedelicscience.org
Help us caption and translate this video on Amara.org: http://www.amara.org/en/videos/ypBoaytF37qb/info/
Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico
Thomas Kingsley Brown, PhD
This presentation is an overview of the MAPS-funded study of long-term outcomes for ibogaine-assisted treatment of opiate dependence for patients at two clinics in Baja California, Mexico. Beginning in September of 2010, the study enrolled thirty US residents seeking ibogaine treatment for opiate dependence at the ...
Continue Reading →